NDC 0378-9671-64 - Ipratropium Bromide and Albuterol Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-9671
- Requested NDC
- 0378-9671-64
- Package NDCs from labels
- 0378-9671-31, 0378-9671-93, 0378-9671-64, 0378-9671-30, 0378-9671-60
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2018-12-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2018-12-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-9671-30 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 CARTON | SOLUTION | 1 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-31 | Ipratropium Bromide and Albuterol Sulfate | 1 in 1 POUCH | SOLUTION | 1 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-60 | Ipratropium Bromide and Albuterol Sulfate | 2 in 1 CARTON | SOLUTION | 2 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 POUCH | SOLUTION | 30 | 7 | |
| 0378-9671-64 | Ipratropium Bromide and Albuterol Sulfate | 3 mL in 1 AMPULE | SOLUTION | 3 | 7 | |
| 0378-9671-93 | Ipratropium Bromide and Albuterol Sulfate | 30 in 1 CARTON | SOLUTION | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-9671-30 | ML - Milliliter | 0378-9671 | fecf8d7a-ca63-4086-a192-cfe09593da7f | 1 | 2016-03-04 |
| 0378-9671-31 | ML - Milliliter | 0378-9671 | 441e8202-3014-467f-839f-1cb56dd1ff5a | 1 | 2015-05-05 |
| 0378-9671-58 | ML - Milliliter | 0378-9671 | e0ed7cbb-725f-41b4-98a8-8e4fbac96aa5 | 1 | 2013-10-17 |
| 0378-9671-60 | ML - Milliliter | 0378-9671 | ac7fec3f-8285-492f-b246-26b74402bbb7 | 1 | 2016-04-04 |
| 0378-9671-91 | ML - Milliliter | 0378-9671 | 32a69a83-77f5-460b-ac59-cdb791096167 | 1 | 2014-04-03 |
| 0378-9671-93 | ML - Milliliter | 0378-9671 | f9a81245-211d-421f-9a2b-9b034708627c | 1 | 2013-07-02 |
| 0378-9671-98 | ML - Milliliter | 0378-9671 | d5fa01b8-04ef-4d82-bc9d-1bc4f51852f7 | 1 | 2015-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Albuterol Sulfate | ACTIVE INGREDIENT | 021SEF3731 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium Bromide | ACTIVE INGREDIENT | J697UZ2A9J | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Albuterol | ACTIVE MOIETY | QF8SVZ843E | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Ipratropium | ACTIVE MOIETY | GR88G0I6UL | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION [MYLAN PHARMACEUTICALS, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albuterol Sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 87ff8be7-3a49-44bd-92de-eb8db24af95b | 2022-12-13 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | HF Acquisition Co LLC, DBA HealthFirst | ad299502-8779-d280-e053-2995a90a7371 | 2022-12-10 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Proficient Rx LP | 0b0587df-b4bd-4fae-9d79-c71362c0314b | 2022-12-01 | Warnings, Adverse reactions | 1437702 J697UZ2A9J 021SEF3731 |
| albuterol sulfate | ALBUTEROL SULFATE | Proficient Rx LP | 918551c7-c3c1-43bc-b575-b33fdb4e96fc | 2022-12-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | d3d2ab1e-8f91-4a4d-aa6b-5a57f59ad56b | 2022-11-01 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Hikma Pharmaceuticals USA Inc. | 71bdbbb9-8696-416d-bed4-7259929c0161 | 2022-07-01 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Hikma Pharmaceuticals USA Inc. | 05c56190-e346-4674-a4f8-049ce632ce2d | 2022-07-01 | J697UZ2A9J | |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Sun Pharmaceutical Industries, Inc. | 231ae8f2-1ec9-4e0f-90a8-11d7b6222576 | 2022-04-13 | Warnings, Adverse reactions | J697UZ2A9J |
| Albuterol | ALBUTEROL | Proficient Rx LP | 895dff1c-d21c-4470-b021-a5b68364c1ec | 2022-04-01 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Exelan Pharmaceuticals, Inc. | 29e35e54-dbd6-4426-993f-893d7a4d69be | 2022-02-10 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 8153d82c-b5c5-4aa2-bce5-b69cf2d23f5d | 2020-10-16 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Bausch & Lomb Incorporated | 3fd850a2-af0f-4291-af5d-52c8d6094e64 | 2019-05-01 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium bromide | IPRATROPIUM BROMIDE | Bausch & Lomb Incorporated | 1e92b86d-66e1-45e4-9e23-f9310c95bf82 | 2019-05-01 | Warnings, Adverse reactions | J697UZ2A9J |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Mylan Pharmaceuticals Inc. | 23c05e9a-9df5-4978-8831-cf562aa4ba92 | 2018-12-12 | Warnings, Adverse reactions | ANDA202496 0378-9671-30 0378-9671-60 0378-9671-31 0378-9671-93 0378-9671-64 0378-9671 00378967164 1437702 96603d2c-6783-4f6c-8b3e-de3eaabcc6aa 23c05e9a-9df5-4978-8831-cf562aa4ba92 J697UZ2A9J 021SEF3731 |
| Ipratropium Bromide | IPRATROPIUM BROMIDE | Mylan Pharmaceuticals Inc. | f625d3e3-c175-4d9a-99ea-dab410b262f1 | 2013-06-24 | Warnings, Adverse reactions | J697UZ2A9J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.